Home › Multiple Myeloma › Illinois › Springfield
Multiple Myeloma clinical trials in Springfield, IL
3 studies for Multiple Myeloma are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Simmons Cancer Institute at SIU, Springfield
- Springfield Clinic Main Campus, Springfield
- HSHS St. John's Hospital, Springfield
- and 1 more
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Memorial Medical Center, Springfield
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Springfield
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)7 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Bladder Cancer6 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma5 studies
- Pancreatic Cancer5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.